echoloc

Quanterix Tech Stack

Ultra-sensitive biomarker detection platform for precision diagnostics

Biotechnology Research Billerica, Massachusetts 201–500 employees Founded 2007 Public Company

Quanterix operates a hardware and reagents platform for detecting biomarkers at scale across oncology, neurology, cardiology, and infectious disease research. The tech stack—Python, C#, C++, .NET, Azure, Salesforce—reflects a dual-track operation: software-driven data handling and manufacturing control systems. Hiring accelerates across support and engineering while the project list (phenocycler instrument launches, planar platform production scheduling, LDT adoption pipeline) signals a shift from research-stage toward commercialization and operational scaling; pain points center on supply-chain robustness, batch-release efficiency, and lab adoption—hallmarks of a hardware company moving from prototype to production volume.

Tech Stack 18 technologies

Core StackPython C# C++ Tableau Salesforce Git .NET Framework WPF Microsoft Sentinel KQL Azure Logic Apps CMMS BMS Niagara Oracle ERP
AdoptingSmartsheet Microsoft Project Excel

What Quanterix Is Building

Challenges

  • Ensuring product quality and supply chain robustness
  • Expanding test adoption across reference labs
  • Assay development challenges
  • Increasing test volume growth
  • Meeting kit cycle time targets
  • Adoption and integration of new technologies
  • Ensuring commercial success across global markets
  • Optimizing internal control environment
  • Inefficient batch release processes
  • Quality event reporting inefficiencies

Active Projects

  • Phenocycler instrument and reagents portfolio
  • Global product launches
  • Pipeline management for lucent ldt adoption
  • Production master schedule for the planar platform
  • Go-to-market strategy for hardware platform launches
  • Redesign internal control infrastructure
  • Control testing
  • Batch release process improvement
  • Quality event process support
  • Integrated marketing campaigns for new spatial products or assays

Hiring Activity

Accelerating35 roles · 15 in 30d

Department

Support
8
Engineering
4
Finance
4
Product
4
Ops
3
Sales
3
Research
2
Security
2

Seniority

Senior
17
Mid
9
Director
3
Principal
3
Junior
2
Lead
1
Manager
1

Notable leadership hires: Spatial Biology Director

Company intelligence

Find more companies like Quanterix by tech stack, pain points and active projects

Get started free

About Quanterix

Quanterix develops Simoa, an ultra-sensitive digital immunoassay platform designed to detect biomarkers earlier and more precisely than conventional methods. The company sells to research institutions, diagnostic labs, and healthcare systems; applications span oncology, neurology, cardiology, inflammation, and infectious disease. Founded in 2007 and headquartered in Billerica, Massachusetts, the company operates at 201–500 employees with active product lines including the Phenocycler instrument and reagent portfolio and the Planar platform. Current focus areas include global product launches, commercialization of a Laboratory Developed Test (LDT), production scaling, and expansion of test adoption across reference labs.

HeadquartersBillerica, Massachusetts
Company Size201–500 employees
Founded2007
Hiring MarketsUnited States, United Kingdom

Frequently Asked Questions

What is Quanterix's main technology platform?

Simoa, an ultra-sensitive digital immunoassay (digital ELISA) platform for biomarker detection. Applications include oncology, neurology, cardiology, inflammation, and infectious disease research and diagnostics.

What tech stack does Quanterix use?

Primary languages: Python, C#, C++. Infrastructure: .NET Framework, Azure, Microsoft Sentinel, Oracle ERP, Salesforce. Manufacturing/ops: CMMS, BMS, Niagara. Recently adopting Smartsheet and Microsoft Project.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size